NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
ID: 345364Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/345364

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-076.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced the P50 Research Center of Excellence Grant Program, aimed at supporting multidisciplinary research on substance use and addiction. This initiative seeks to establish research centers that will conduct innovative studies, mentor new investigators, and serve as national resources for educational outreach in the field of drug abuse research. Eligible applicants include a diverse range of organizations, such as higher education institutions and community-based organizations, with funding available for projects not exceeding $10 million over a maximum period of five years. Key deadlines for application submissions begin on August 25, 2023, with the final submission date set for September 25, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-076-Full-Announcement.html
    PAR-23-076.html
    The National Institutes of Health (NIH) through the National Institute on Drug Abuse (NIDA) has released a funding opportunity announcement for the P50 Research Center of Excellence Grant Program. This initiative aims to support multidisciplinary research on substance use and addiction, including its intersection with HIV. The centers are expected to foster innovative science, mentor new investigators, and serve as national resources to enhance educational outreach. Applications are invited from various eligible organizations, including higher education institutions, nonprofits, and government entities, with budgets not exceeding $10 million for a maximum project period of five years. Key submission dates start on August 25, 2023, with deadlines for application submissions occurring periodically up to September 25, 2025. Applicants must adhere to strict guidelines and include a Plan for Enhancing Diverse Perspectives to ensure inclusivity and effectiveness in research. Each center should exhibit scientific innovation, coordination among research projects, and potential to become a valuable resource in the substance use research community, ultimately influencing methods and practices within the field.
    Similar Opportunities
    NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) to support institutional research career development programs aimed at clinician scientists. This grant is designed to provide intensive supervised research training and career development experiences, ultimately leading to research independence in the field of substance use and substance use disorders. The program encourages applications focusing on various scientific areas, including neuroimaging, genetics, medication development, and implementation science, among others. Interested applicants from private institutions of higher education should prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis post date of July 3, 2025, and a close date of August 5, 2025. For further inquiries, applicants can contact Lindsey Friend, Ph.D., at NIDA via email at NIDATraining@nida.nih.gov or by phone at 301-402-1428.
    Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)." This initiative aims to support educational activities that promote diversity in the biomedical and behavioral sciences, particularly focusing on substance use and addiction research, by encouraging applications from institutions committed to underrepresented groups. The program seeks to develop a diverse pool of researchers through mentorship and educational activities tailored to various career stages, with a budget request limit of $250,000 in direct costs annually for up to five years. Interested applicants must submit their proposals by 5:00 PM local time on November 13, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.
    NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is inviting applications for Program Project Grants (P01 Clinical Trial Optional) aimed at fostering collaborative, multidisciplinary research on substance use disorders. Applicants must propose a minimum of three interrelated research projects that demonstrate scientific and administrative synergy under a unifying theme, addressing critical issues such as neuroscience, genetics, behavior, prevention, treatment, and health services related to substance use. This funding opportunity emphasizes inclusivity, requiring a Plan for Enhancing Diverse Perspectives (PEDP) and encouraging participation from underrepresented groups, with a maximum project duration of five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by January 7, 2026.
    Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Substance Use/Substance Use Disorder Dissertation Research Award (R36), aimed at supporting doctoral candidates for up to two years in their dissertation research related to substance use disorders. This grant, under the National Institute on Drug Abuse (NIDA), encourages applications from diverse backgrounds and focuses on advancing knowledge in prevention, diagnosis, and treatment of substance misuse and related health outcomes, excluding independent clinical trials. Eligible applicants can receive up to $50,000 per year for innovative research aligned with NIDA’s strategic plan, with applications due by September 7, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Research Education Program for Clinical Researchers and Clinicians under Funding Opportunity Number PAR-25-204, aimed at enhancing the training of clinicians and clinical researchers in substance use disorder (SUD) research. This program seeks to address the shortage of qualified professionals in the field by supporting educational activities that develop skills and provide hands-on research experiences, particularly targeting underrepresented groups in the workforce. With a budget of up to $350,000 annually for a project duration not exceeding five years, the program is open for applications starting February 11, 2025. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Mechanism for Time-Sensitive Substance Use Research" under the National Institute on Drug Abuse (NIDA). This grant, designated as R21, aims to support pilot, feasibility, and exploratory research addressing urgent issues in substance use epidemiology and health services, particularly in response to sudden increases in substance misuse and emerging public health challenges. Eligible applicants include a wide range of entities such as educational institutions, governmental bodies, and nonprofit organizations, with a budget cap of $275,000 over two years. Interested parties must submit their applications by September 9, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)" aimed at supporting research into effective interventions for substance use disorders (SUDs) and overdose. This cooperative agreement encourages applications for preclinical and clinical studies focusing on pharmacotherapies, device-based treatments, digital therapeutics, and behavioral interventions, with the goal of advancing these interventions towards regulatory approval or clinical adoption. The funding amount can reach up to $3 million, and applications are due by 5:00 PM local time, with multiple submission cycles from October 2025 to August 2028. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced the Cutting-Edge Basic Research Awards (CEBRA) aimed at promoting innovative research in the field of substance use disorders (SUDs). This funding opportunity invites exploratory applications that focus on high-risk, high-impact research not currently represented in NIDA’s portfolio, encouraging the development of revolutionary methodologies or the testing of transformative hypotheses. The program seeks to stimulate novel insights into the etiology and treatment of SUDs by integrating diverse scientific disciplines, with a maximum budget of $275,000 for each two-year project, allowing no more than $150,000 to be requested in a single year. Applications are due by February 10, 2025, and the funding opportunity will remain open until August 12, 2027; for further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Neural Ensembles & Used Substances (NExUS) Collaboratory : Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Neural Ensembles & Used Substances (NExUS) Collaboratory," aimed at building a multimodal inventory of cell ensembles that encode the effects of addictive substances. This initiative seeks to advance the understanding of neural cell populations and their alterations due to substance-related experiences, with specific goals including the collection of granular datasets, integration of various data modalities, and the development of analytical tools for ensemble activity. The grant, which has a funding ceiling of $700,000 and anticipates awarding four grants, is open to a diverse range of applicants, including tribal governments, federal agencies, and non-domestic entities. Interested parties can reach out to Olivier Berton at olivier.berton@nih.gov or by phone at 301-827-7771 for further information, with applications expected to be submitted by June 2, 2026, and project start dates anticipated for April 1, 2027.
    Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for a Specialized Center-Cooperative Agreement (U54) aimed at establishing a Dynamic and Adaptable Infrastructure for Drug Development and Outreach to enhance the research community's efforts in repurposing and repositioning medications for Substance Use Disorders (SUDs). The initiative seeks to support academic and biotech researchers by providing comprehensive drug development services, including regulatory guidance, intellectual property consultations, and technical support, while excluding clinical trials. This funding opportunity is critical for accelerating the drug development pipeline for SUDs, with NIH committing $2.5 million for one award in FY 2026, and applications are due by January 28, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-26-020.html.